SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

Why did Zim’s CEO sell $40 million in shares before the $4.2 billion Hapag-Lloyd deal?

Wiz CEO Assaf Rappaport’s tech group to acquire Israeli broadcaster Reshet 13 from Len Blavatnik

“Iran is attempting an inflationary attack on the American consumer, raising fuel prices to create political pressure to end the war”

“Iran may decide: If all that didn’t work, we should proceed like North Korea”

Buzz

Most popular

Daily

Weekly

1

Wiz billionaires forming private family office to manage proceeds from $32 billion Google exit

2

One-year-old AI startup Wonderful raises $150 million Series B at $2 billion valuation

3

“Within 10 years, there will be at least 10 more Israeli companies like Wiz”

4

Cyber startup Onyx Security raises $35 million to control AI agents in organizations

5

Tel Aviv train station hit by cyberattack with fake missile alerts

Johnson & Johnson

8 stories about Johnson & Johnson

ג'ונסון אנד ג'ונסון מטה החברה בניו ג'רזי ארה"ב

J&J’s $1.7 billion bet on Israeli heart device falters after FDA panel vote

Advisors reject effectiveness of V-Wave’s implant, threatening the contingent value of last year’s acquisition.

ניר ברקת שר הכלכלה ו אלי ברקת

Riding the V-Wave exit: Who are the big winners?

21.08.24|Meir Orbach

The pharmaceutical giant Johnson & Johnson announced on Tuesday the purchase of the Israeli medical device company for up to $1.7 billion. BRM is the largest shareholder in the company and is expected to receive at least $100 million. The second largest shareholder is Pontifax VC of Tomer Kariv and Ran Nussbaum. Other notable investors include Ilan Grinboim and Prof. Benad Goldwasser.

ג'ונסון אנד ג'ונסון ג'ונסון _alt ג'ונסון

Johnson & Johnson to acquire Israeli medical device maker V-Wave for up to $1.7 billion

20.08.24|Meir Orbach

V-Wave's device is implanted in the heart through a minimally invasive procedure to help reduce heart failure and other events.

הדמיה חיסון תרופה קורונה covid 19

Place your bets: Which company will reach a Covid-19 vaccine first?

02.08.20|Sophie Shulman

Moderna may be creating all the buzz, but it is the youngest and least experienced of the contestants, playing an all or nothing game

אורן כהן מייסד חברת OrthoSpin

Orthopedic Brace Startup OrthoSpin Raises $5 Million

31.03.20|Adi Pick

OrthoSpin develops an electric brace designed to help with bone lengthening, setting complex fractures, and correcting deformities

ועידת MIND THE DATA 2016 אייל גורה מייסד ויו״ר Zebra Medical

Zebra Medical Partners With Johnson & Johnson Subsidiary

19.12.19|Meir Orbach

DePuy Synthes, a subsidiary of Johnson & Johnson, develops surgical devices used to treat fractures and orthopedic injuries

Johnson & Johnson Subsidiary Janssen Partners With Sustained Drug Release Company UroGen

The two companies will collaborate on the research of a “therapeutic area of mutual interest”

Phage Therapies Company BiomX Signs Johnson & Johnson Collaboration

13.12.18|Lilach Baumer

Bacteriophages are viruses that invade bacterial cells and can be used to treat bacterial infections. Phage therapy is often discussed as an alternative to traditional antibiotics